The acceptance of traditional Chinese medicine among patients with Parkinson’s disease: A hospital survey

IF 4.2 2区 医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Journal of Integrative Medicine-Jim Pub Date : 2024-03-01 DOI:10.1016/j.joim.2024.03.005
Peng Wang , Jing Hong , Zhu-qian Tang , Bi-zhen Gong , Xiao-rong Qi , Han Jiang , Bo Pan , Qi Chen
{"title":"The acceptance of traditional Chinese medicine among patients with Parkinson’s disease: A hospital survey","authors":"Peng Wang ,&nbsp;Jing Hong ,&nbsp;Zhu-qian Tang ,&nbsp;Bi-zhen Gong ,&nbsp;Xiao-rong Qi ,&nbsp;Han Jiang ,&nbsp;Bo Pan ,&nbsp;Qi Chen","doi":"10.1016/j.joim.2024.03.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>The efficacy of medications for Parkinson’s disease (PD) tend to decline over time, which has a serious impact on patients’ health and quality of life. To some extent, traditional Chinese medicine (TCM) can resolve the distressing problem of ineffective dopaminergic medication in PD patients. The purpose of this study was to investigate the attitude, acceptance, and independent predictors of TCM in PD patients admitted to the outpatient department of a tertiary hospital.</p></div><div><h3>Methods</h3><p>A cross-sectional study of PD patients was conducted in the outpatient department of a large tertiary hospital in Beijing from March 2022 to June 2023. A self-report questionnaire was developed to investigate PD patients’ attitudes and acceptance of TCM based on the questionnaire. Multivariate logistic regression analyses were also performed to further clarify the independent predictors influencing patients’ adoption of TCM therapy.</p></div><div><h3>Results</h3><p>A total of 397 patients completed the questionnaire, of which 78.09% were willing to be treated with TCM and 21.91% indicated that they were not willing to use TCM. Multifactorial logistic regression analysis showed that several parameters were correlated with a patient’s willingness to include TCM in their therapeutic regime. These included education level of a bachelor’s degree (odds ratio [OR) = 8.554; 95% confidence interval [CI]: 4.112–17.794; <em>P</em> &lt; 0.001, <em>vs</em> junior high school education), living in an urban setting (OR = 8.022; 95% CI: 4.577–14.060; <em>P</em> &lt; 0.001, <em>vs</em> rural), having other underlying diseases (OR = 5.126; 95% CI: 3.078–8.537; <em>P</em> &lt; 0.001, <em>vs</em> none), having previously used TCM (OR = 3.083; 95% CI: 1.852–5.134; <em>P</em> &lt; 0.001, <em>vs</em> not used), believing that TCM therapy is safe (OR = 3.530; 95% CI: 1.446–8.616; <em>P</em> = 0.006, <em>vs</em> not thought), believing that TCM therapy is effective (OR = 3.859; 95% CI: 1.482–10.047; <em>P</em> = 0.006, <em>vs</em> not understood), and being willing to discuss ongoing TCM therapy with an attending physician (OR = 62.468; 95% CI: 30.350–128.574; <em>P</em> &lt; 0.001, <em>vs</em> not informed).</p></div><div><h3>Conclusion</h3><p>This study initially investigated the acceptance, attitude, and independent predictors of TCM use among PD patients. To expand the prevalence of TCM use among patients with PD, we recommend to broadening the public outreach for TCM via contemporary means of Internet and broadcast communication, enhancing access to TCM services in rural communities, and strengthening the communication between doctors and patients.</p><p>Please cite this article as: Wang P, Hong J, Tang ZQ, Gong BZ, Qi XR, Jiang H, Pan B, Chen Q. The acceptance of traditional Chinese medicine among patients with Parkinson’s disease: A hospital survey. <em>J Integr Med</em>. 2024; 22(2): 180–187.</p></div>","PeriodicalId":48599,"journal":{"name":"Journal of Integrative Medicine-Jim","volume":null,"pages":null},"PeriodicalIF":4.2000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Integrative Medicine-Jim","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2095496424000293","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

The efficacy of medications for Parkinson’s disease (PD) tend to decline over time, which has a serious impact on patients’ health and quality of life. To some extent, traditional Chinese medicine (TCM) can resolve the distressing problem of ineffective dopaminergic medication in PD patients. The purpose of this study was to investigate the attitude, acceptance, and independent predictors of TCM in PD patients admitted to the outpatient department of a tertiary hospital.

Methods

A cross-sectional study of PD patients was conducted in the outpatient department of a large tertiary hospital in Beijing from March 2022 to June 2023. A self-report questionnaire was developed to investigate PD patients’ attitudes and acceptance of TCM based on the questionnaire. Multivariate logistic regression analyses were also performed to further clarify the independent predictors influencing patients’ adoption of TCM therapy.

Results

A total of 397 patients completed the questionnaire, of which 78.09% were willing to be treated with TCM and 21.91% indicated that they were not willing to use TCM. Multifactorial logistic regression analysis showed that several parameters were correlated with a patient’s willingness to include TCM in their therapeutic regime. These included education level of a bachelor’s degree (odds ratio [OR) = 8.554; 95% confidence interval [CI]: 4.112–17.794; P < 0.001, vs junior high school education), living in an urban setting (OR = 8.022; 95% CI: 4.577–14.060; P < 0.001, vs rural), having other underlying diseases (OR = 5.126; 95% CI: 3.078–8.537; P < 0.001, vs none), having previously used TCM (OR = 3.083; 95% CI: 1.852–5.134; P < 0.001, vs not used), believing that TCM therapy is safe (OR = 3.530; 95% CI: 1.446–8.616; P = 0.006, vs not thought), believing that TCM therapy is effective (OR = 3.859; 95% CI: 1.482–10.047; P = 0.006, vs not understood), and being willing to discuss ongoing TCM therapy with an attending physician (OR = 62.468; 95% CI: 30.350–128.574; P < 0.001, vs not informed).

Conclusion

This study initially investigated the acceptance, attitude, and independent predictors of TCM use among PD patients. To expand the prevalence of TCM use among patients with PD, we recommend to broadening the public outreach for TCM via contemporary means of Internet and broadcast communication, enhancing access to TCM services in rural communities, and strengthening the communication between doctors and patients.

Please cite this article as: Wang P, Hong J, Tang ZQ, Gong BZ, Qi XR, Jiang H, Pan B, Chen Q. The acceptance of traditional Chinese medicine among patients with Parkinson’s disease: A hospital survey. J Integr Med. 2024; 22(2): 180–187.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
帕金森病患者对中医药的接受程度:一项医院调查
帕金森病(Parkinson's disease,PD)的药物疗效往往随着时间的推移而下降,严重影响患者的健康和生活质量。中医药在一定程度上可以解决帕金森病患者多巴胺能药物治疗无效的困扰。本研究旨在调查一家三甲医院门诊部收治的帕金森病患者对中医药的态度、接受程度和独立预测因素。本研究于 2022 年 3 月至 2023 年 6 月在北京一家大型三甲医院门诊部对 PD 患者进行了横断面研究。根据问卷编制了一份自我报告问卷,以调查 PD 患者对中医药的态度和接受程度。为进一步明确影响患者采用中医药治疗的独立预测因素,还进行了多变量逻辑回归分析。共有397名患者填写了问卷,其中78.09%的患者愿意接受中医治疗,21.91%的患者表示不愿意使用中医治疗。多因素逻辑回归分析表明,有几项参数与患者是否愿意将中医纳入其治疗方案相关。这些参数包括本科教育程度(几率比[OR] = 8.554; 95%置信区间[CI]:这些因素包括:教育程度为本科(比值比 [OR] = 8.554;95% 置信区间 [CI]:4.112-17.794;< 0.001,初中教育程度)、居住在城市(比值比 [OR] = 8.022;95% 置信区间 [CI]:4.577-14.060;< 0.001,农村)、患有其他基础疾病(比值比 [OR] = 5.126;95% 置信区间 [CI]:3.078-8.537;< 0.001,无)、以前使用过中医药(比值比 [OR] = 3.083;95% 置信区间 [CI]:1.852-5.134;< 0.001,未使用过)、认为中医药治疗是安全的(比值比 [OR] = 3.530;95% CI:1.446-8.616;=0.006,不认为),认为中医治疗有效(OR=3.859;95% CI:1.482-10.047;=0.006,不了解),愿意与主治医生讨论正在进行的中医治疗(OR=62.468;95% CI:30.350-128.574;<0.001,不了解)。本研究初步调查了PD患者对中医药的接受程度、态度以及使用中医药的独立预测因素。为了扩大中医药在PD患者中的使用率,我们建议通过互联网和广播等现代传播手段扩大中医药的公众宣传,提高农村社区中医药服务的可及性,并加强医患之间的沟通。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Integrative Medicine-Jim
Journal of Integrative Medicine-Jim Medicine-Complementary and Alternative Medicine
CiteScore
9.20
自引率
4.20%
发文量
3319
期刊介绍: The predecessor of JIM is the Journal of Chinese Integrative Medicine (Zhong Xi Yi Jie He Xue Bao). With this new, English-language publication, we are committed to make JIM an international platform for publishing high-quality papers on complementary and alternative medicine (CAM) and an open forum in which the different professions and international scholarly communities can exchange views, share research and their clinical experience, discuss CAM education, and confer about issues and problems in our various disciplines and in CAM as a whole in order to promote integrative medicine. JIM is indexed/abstracted in: MEDLINE/PubMed, ScienceDirect, Emerging Sources Citation Index (ESCI), Scopus, Embase, Chemical Abstracts (CA), CAB Abstracts, EBSCO, WPRIM, JST China, Chinese Science Citation Database (CSCD), and China National Knowledge Infrastructure (CNKI). JIM Editorial Office uses ThomsonReuters ScholarOne Manuscripts as submitting and review system (submission link: http://mc03.manuscriptcentral.com/jcim-en). JIM is published bimonthly. Manuscripts submitted to JIM should be written in English. Article types include but are not limited to randomized controlled and pragmatic trials, translational and patient-centered effectiveness outcome studies, case series and reports, clinical trial protocols, preclinical and basic science studies, systematic reviews and meta-analyses, papers on methodology and CAM history or education, conference proceedings, editorials, commentaries, short communications, book reviews, and letters to the editor. Our purpose is to publish a prestigious international journal for studies in integrative medicine. To achieve this aim, we seek to publish high-quality papers on any aspects of integrative medicine, such as acupuncture and traditional Chinese medicine, Ayurveda medicine, herbal medicine, homeopathy, nutrition, chiropractic, mind-body medicine, taichi, qigong, meditation, and any other modalities of CAM; our commitment to international scope ensures that research and progress from all regions of the world are widely covered. These ensure that articles published in JIM have the maximum exposure to the international scholarly community. JIM can help its authors let their papers reach the widest possible range of readers, and let all those who share an interest in their research field be concerned with their study.
期刊最新文献
Effectiveness and safety of adjunctive non-drug measures in improving respiratory symptoms among patients with severe COVID-19: A multicenter randomized controlled trial. Luteolin protects against myocardial ischemia/reperfusion injury by reducing oxidative stress and apoptosis through the p53 pathway. Editorial Board Scientific guidelines for preclinical research on potentised preparations manufactured according to current pharmacopoeias—the PrePoP guidelines Efficacy and safety of Qingfei Huatan formula in the treatment of acute exacerbation of chronic obstructive pulmonary disease: A multi-centre, randomised, double-blind, placebo-controlled trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1